相似文献
1
Do We Have a Winner? Advocating for SBRT in HCC Management.
Clin Transl Radiat Oncol. 2024 Feb 2;45:100740. doi: 10.1016/j.ctro.2024.100740. eCollection 2024 Mar.
2
Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102386. doi: 10.1016/j.jceh.2024.102386. Epub 2024 Aug 3.
3
Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma.
Drug Discov Ther. 2015 Oct;9(5):372-9. doi: 10.5582/ddt.2015.01056.
4
Radiotherapy for HCC: Ready for prime time?
JHEP Rep. 2019 May 21;1(2):131-137. doi: 10.1016/j.jhepr.2019.05.004. eCollection 2019 Aug.
5
Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination.
Cancers (Basel). 2021 Jan 7;13(2):192. doi: 10.3390/cancers13020192.
6
Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
Yonsei Med J. 2018 Oct;59(8):912-922. doi: 10.3349/ymj.2018.59.8.912.
7
Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review.
Cost Eff Resour Alloc. 2020 Jan 10;18:1. doi: 10.1186/s12962-019-0198-z. eCollection 2020.
8
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
J Cancer Res Clin Oncol. 2015 Jul;141(7):1301-9. doi: 10.1007/s00432-015-1929-y. Epub 2015 Feb 3.
9
Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm.
JHEP Rep. 2024 Jun 25;6(10):101151. doi: 10.1016/j.jhepr.2024.101151. eCollection 2024 Oct.
10
Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.
Radiology. 2017 May;283(2):460-468. doi: 10.1148/radiol.2016161509. Epub 2017 Jan 3.
引用本文的文献
1
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy.
Clin Transl Radiat Oncol. 2024 Nov 12;50:100887. doi: 10.1016/j.ctro.2024.100887. eCollection 2025 Jan.
2
Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy.
Clin Transl Radiat Oncol. 2024 Sep 13;49:100859. doi: 10.1016/j.ctro.2024.100859. eCollection 2024 Nov.
3
Complex Multi-site Stereotactic Body Re-irradiation With CT-Guided Online Adaptive Radiotherapy.
Cureus. 2024 Sep 3;16(9):e68559. doi: 10.7759/cureus.68559. eCollection 2024 Sep.
4
Radiomodulating Properties of Superparamagnetic Iron Oxide Nanoparticle (SPION) Agent Ferumoxytol on Human Monocytes: Implications for MRI-Guided Liver Radiotherapy.
Cancers (Basel). 2024 Mar 28;16(7):1318. doi: 10.3390/cancers16071318.
本文引用的文献
1
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma.
Liver Cancer. 2023 Oct 1;13(3):265-276. doi: 10.1159/000533425. eCollection 2024 Jun.
2
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma.
Int J Mol Sci. 2023 Nov 26;24(23):16773. doi: 10.3390/ijms242316773.
3
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines.
Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):337-351. doi: 10.1016/j.ijrobp.2023.08.015. Epub 2023 Aug 18.
4
Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.
Cancer. 2023 Nov 15;129(22):3554-3563. doi: 10.1002/cncr.34965. Epub 2023 Jul 28.
5
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Cancers (Basel). 2023 May 17;15(10):2786. doi: 10.3390/cancers15102786.
6
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
7
Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial).
Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):45-52. doi: 10.1016/j.ijrobp.2023.03.064. Epub 2023 Apr 8.
8
Novel unconventional radiotherapy techniques: Current status and future perspectives - Report from the 2nd international radiation oncology online seminar.
Clin Transl Radiat Oncol. 2023 Feb 23;40:100605. doi: 10.1016/j.ctro.2023.100605. eCollection 2023 May.
9
For Hepatocellular Carcinoma Treated with Yttrium-90 Microspheres, Dose Volumetrics on Post-Treatment Bremsstrahlung SPECT/CT Predict Clinical Outcomes.
Cancers (Basel). 2023 Jan 20;15(3):645. doi: 10.3390/cancers15030645.
10
Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis.
JHEP Rep. 2022 Sep 22;5(1):100594. doi: 10.1016/j.jhepr.2022.100594. eCollection 2023 Jan.
Zotero 插件